Halozyme Therapeutics posts strong Q1 2025 earnings with 35% revenue growth, robust pipeline, and rising royalties.

GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

Discover the critical indicators medical professionals use to detect kidney damage early, from blood tests and urine analysis ...

But few could have predicted that appearance would be his last and that just hours later, he would leave unfinished his ...

As Donald Trump completes the first 100 days of his second term, the consequences of his early health care decisions are ...

Diana Fishbein, Nova Institute for Health scholar, ASDN Coordinating Committee member, and University of North Carolina ...

An orphan, as so many were in those terrible years, his bedside chart read Baby M. This child had never been ... or infants—living with HIV/AIDS. Today, of course, effective antiretroviral therapies ...

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

Photo credit: Dann Tardif/Getty Images. Here is an overview of some of the common and more severe HIV drug side effects. The following chart lists some HIV medication side effects that are more ...

AARP also calls on Congress to protect and strengthen Medicare’s ability to negotiate lower drug prices for millions of older ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

The Food and Drug ... HIV revenue would be largely flat in 2025 because of changes to the federal government's Medicare health plan for people age 65 and over aimed at reducing out-of-pocket costs ...